JP2022537994A5 - - Google Patents
Info
- Publication number
- JP2022537994A5 JP2022537994A5 JP2021575050A JP2021575050A JP2022537994A5 JP 2022537994 A5 JP2022537994 A5 JP 2022537994A5 JP 2021575050 A JP2021575050 A JP 2021575050A JP 2021575050 A JP2021575050 A JP 2021575050A JP 2022537994 A5 JP2022537994 A5 JP 2022537994A5
- Authority
- JP
- Japan
- Prior art keywords
- disease
- formula
- compound
- pharmaceutically acceptable
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19183641.0 | 2019-07-01 | ||
| EP19183641 | 2019-07-01 | ||
| PCT/EP2020/068181 WO2021001286A1 (en) | 2019-07-01 | 2020-06-29 | A substituted tetrahydroisoquinoline derivative as a d1 positive allosteric modulator |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022537994A JP2022537994A (ja) | 2022-08-31 |
| JP2022537994A5 true JP2022537994A5 (cg-RX-API-DMAC7.html) | 2023-07-04 |
| JP7618597B2 JP7618597B2 (ja) | 2025-01-21 |
Family
ID=67137842
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021575050A Active JP7618597B2 (ja) | 2019-07-01 | 2020-06-29 | D1ポジティブアロステリックモジュレーターとしての置換されたテトラヒドロイソキノリン誘導体 |
Country Status (28)
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020131671A1 (en) | 2018-12-18 | 2020-06-25 | Eli Lilly And Company | Dose regimens for use of ly3154207 in the treatment of dopaminergic cns disorders |
| EP4200280B1 (en) | 2020-10-07 | 2024-02-21 | Eli Lilly And Company | Phenyl-3,4-dihydroisoquinolin-2(1h)-yl-ethan-1-one derivatives as dopamine d1 receptor positive allosteric modulators |
| CN117337173A (zh) * | 2021-03-09 | 2024-01-02 | 伊莱利利公司 | 美维达林和其他d1正向别构调节剂用于减缓帕金森氏病进展的用途 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010520217A (ja) | 2007-03-01 | 2010-06-10 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | ヒスタミンh3受容体のモジュレーターとしてのテトラヒドロイソキノリン化合物 |
| KR101284796B1 (ko) | 2011-10-05 | 2013-07-10 | (주)포인트엔지니어링 | 캔 패지키 타입의 광 디바이스 제조 방법 및 이에 의해 제조된 광 디바이스 |
| US9278960B2 (en) | 2011-11-03 | 2016-03-08 | Merck Sharp & Dohme Corp. | Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their use |
| JO3316B1 (ar) | 2013-05-30 | 2019-03-13 | Lilly Co Eli | مركبات 3، 4-داي هيدرو أيزو كوينولين -2(1h)-يل |
| EA035544B1 (ru) | 2014-10-08 | 2020-07-03 | Юсб Байофарма Спрл | Производные тетрагидроизохинолина |
| CN108884050B (zh) * | 2016-04-13 | 2022-07-05 | Ucb生物制药私人有限公司 | 四氢异喹啉衍生物 |
| EP3596060B1 (en) * | 2017-03-16 | 2023-09-20 | F. Hoffmann-La Roche AG | New bicyclic compounds as atx inhibitors |
| TWI725408B (zh) | 2018-04-20 | 2021-04-21 | 美商美國禮來大藥廠 | 多巴胺d1受體正向異位調節劑 |
-
2020
- 2020-06-29 MX MX2021015872A patent/MX2021015872A/es unknown
- 2020-06-29 SG SG11202112539XA patent/SG11202112539XA/en unknown
- 2020-06-29 ES ES20735361T patent/ES3069145T3/es active Active
- 2020-06-29 CN CN202080043673.9A patent/CN114008032B/zh active Active
- 2020-06-29 PE PE2021002217A patent/PE20220373A1/es unknown
- 2020-06-29 PL PL20735361.6T patent/PL3993795T3/pl unknown
- 2020-06-29 JP JP2021575050A patent/JP7618597B2/ja active Active
- 2020-06-29 AU AU2020299705A patent/AU2020299705B2/en active Active
- 2020-06-29 RS RS20260706A patent/RS68243B1/en unknown
- 2020-06-29 US US17/621,871 patent/US12358890B2/en active Active
- 2020-06-29 MY MYPI2021006863A patent/MY210362A/en unknown
- 2020-06-29 EP EP20735361.6A patent/EP3993795B1/en active Active
- 2020-06-29 WO PCT/EP2020/068181 patent/WO2021001286A1/en not_active Ceased
- 2020-06-29 HR HRP20260599TT patent/HRP20260599T1/hr unknown
- 2020-06-29 BR BR112021022379A patent/BR112021022379A2/pt unknown
- 2020-06-29 MA MA56445A patent/MA56445B1/fr unknown
- 2020-06-29 UA UAA202106080A patent/UA130613C2/uk unknown
- 2020-06-29 IL IL289317A patent/IL289317B2/en unknown
- 2020-06-29 CA CA3139622A patent/CA3139622A1/en active Pending
- 2020-06-29 PH PH1/2021/552819A patent/PH12021552819A1/en unknown
- 2020-06-29 KR KR1020227002603A patent/KR102949226B1/ko active Active
- 2020-06-30 AR ARP200101852A patent/AR119317A1/es unknown
- 2020-06-30 TW TW109122034A patent/TWI842923B/zh active
-
2021
- 2021-11-08 CL CL2021002949A patent/CL2021002949A1/es unknown
- 2021-11-17 ZA ZA2021/09194A patent/ZA202109194B/en unknown
- 2021-12-23 CO CONC2021/0017740A patent/CO2021017740A2/es unknown
- 2021-12-30 SA SA521431274A patent/SA521431274B1/ar unknown
-
2022
- 2022-01-31 EC ECSENADI20227557A patent/ECSP22007557A/es unknown